VAERS reports by lot

Janssen (J&J) COVID-19 lot 1808986: VAERS reports

388 VAERS reports list lot 1808986 as a Janssen (J&J) COVID-19 vaccine, received between 2021-05-12 and 2024-07-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
388
Reports
10%
Marked serious
10
With a death outcome
20
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological32725%
General / Systemic (non-local)26721%
Cardiac / Cardiovascular14511%
Gastrointestinal12410%
Musculoskeletal1008%
Dermatological (non-injection-site)917%
Respiratory776%
Injection-site / Local reaction655%
Allergic / Anaphylactic363%
Thrombotic / Hematological322%
Psychiatric / Neuropsychiatric252%
Reproductive / Menstrual71%
Autoimmune / Immune-mediated60%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey41
New York28
California22
Texas20
Virginia19
Maryland19
Wisconsin17
Pennsylvania15
Florida15
North Carolina14
Massachusetts14
Illinois13

Reports by month received

2021-05110
2021-0677
2021-0737
2021-0834
2021-0964
2021-1023
2021-118
2021-123
2022-019
2022-026
2022-031
2022-045
2022-052
2022-111
2022-121
2023-011
2023-042
2023-052
2023-061
2024-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.